$CNS
COHEN & STEERS, INC. Stock $cns

$cns Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000128481224000195 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$121.7M	$122.7M
YoY Change	0.9%	-2.67%
Cost Of Revenue	$13.27M	$13.40M
YoY Change	-0.44%	-5.78%
Gross Profit	$108.5M	$109.3M
YoY Change	1.07%	-2.28%
Gross Profit Margin	89.1%	89.08%
Selling, General & Admin	$67.78M	$66.80M
YoY Change	3.29%	1.24%
% of Gross Profit	62.5%	61.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.268M	$2.254M
YoY Change	170.32%	128.14%
% of Gross Profit	2.09%	2.06%
Operating Expenses	$70.05M	$82.45M
YoY Change	5.4%	23.11%
Operating Profit	$38.40M	$40.27M
YoY Change	-5.97%	-10.32%
Interest Expense	$3.039M	$4.903M
YoY Change	-19.69%	68.6%
% of Operating Profit	7.91%	12.18%
Other Income/Expense, Net	-$483.0K	$5.037M
YoY Change	-57.41%	-494.75%
Pretax Income	$40.96M	$45.30M
YoY Change	-5.82%	-2.64%
Income Tax	$10.88M	$10.89M
% Of Pretax Income	26.57%	24.03%
Net Earnings	$31.77M	$34.00M
YoY Change	-0.02%	-3.71%
Net Earnings / Revenue	26.1%	27.71%
Basic Earnings Per Share	$0.63	$0.69
Diluted Earnings Per Share	$0.63	$0.68
COMMON SHARES
Basic Shares Outstanding	50.54M shares	49.52M shares
Diluted Shares Outstanding	50.77M shares	49.84M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.0M	$99.52M
YoY Change	-31.63%	-33.44%
Cash & Equivalents	$122.0M	$99.52M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$65.27M	$75.33M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$187.3M	$174.9M
YoY Change	-22.51%	-22.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$70.33M	$68.39M
YoY Change	93.59%	453.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$13.00K	$13.00K
YoY Change	-38.1%	-35.0%
Other Assets
YoY Change
Total Long-Term Assets	$596.8M	$505.9M
YoY Change	55.69%	27.32%
TOTAL ASSETS
Total Short-Term Assets	$187.3M	$174.9M
Total Long-Term Assets	$596.8M	$505.9M
Total Assets	$784.1M	$680.7M
YoY Change	25.45%	9.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$595.0K	$17.79M
YoY Change	-52.67%	1354.95%
Accrued Expenses	$174.4M	$158.5M
YoY Change	18.6%	2.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$184.7M	$195.2M
YoY Change	17.58%	10.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$14.95M	$10.70M
YoY Change	-37.69%	-38.52%
Total Long-Term Liabilities	$14.95M	$10.70M
YoY Change	-37.69%	-38.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$184.7M	$195.2M
Total Long-Term Liabilities	$14.95M	$10.70M
Total Liabilities	$199.6M	$205.9M
YoY Change	10.25%	6.24%
SHAREHOLDERS EQUITY
Retained Earnings	-$153.4M	-$154.4M
YoY Change	-5.47%	-6.48%
Common Stock	$574.0K	$564.0K
YoY Change	2.87%	1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$291.2M	$291.1M
YoY Change	7.52%	7.56%
Treasury Stock Shares
Shareholders Equity	$463.2M	$378.9M
YoY Change
Total Liabilities & Shareholders Equity	$784.1M	$680.7M
YoY Change	25.45%	9.2%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$31.77M	$34.00M
YoY Change	-0.02%	-3.71%
Depreciation, Depletion And Amortization	$2.268M	$2.254M
YoY Change	170.32%	128.14%
Cash From Operating Activities	$31.37M	$4.863M
YoY Change	-41.55%	-132.49%
INVESTING ACTIVITIES
Capital Expenditures	$4.239M	$4.326M
YoY Change	-72.73%	-5.67%
Acquisitions
YoY Change
Other Investing Activities	-$70.14M	-$25.04M
YoY Change	-462.87%	-17.7%
Cash From Investing Activities	-$74.38M	-$29.36M
YoY Change	-2065.18%	-16.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	65.76M	-$64.26M
YoY Change	-315.04%	38.14%
NET CHANGE
Cash From Operating Activities	31.37M	$4.863M
Cash From Investing Activities	-74.38M	-$29.36M
Cash From Financing Activities	65.76M	-$64.26M
Net Change In Cash	22.75M	-$88.76M
YoY Change	-15.37%	-8.01%
FREE CASH FLOW
Cash From Operating Activities	$31.37M	$4.863M
Capital Expenditures	$4.239M	$4.326M
Free Cash Flow	$27.14M	$537.0K
YoY Change	-28.85%	-102.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-308000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	122710000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126082000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	52003000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	48857000	usd
CY2024Q1	us-gaap	Sponsor Fees SponsorFees	13395000	usd
CY2023Q1	us-gaap	Sponsor Fees SponsorFees	14216000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14793000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17122000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2254000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	988000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	82445000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	81183000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	40265000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	44899000	usd
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3919000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3216000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	984000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-308000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	134000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1276000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5037000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1632000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45302000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	46531000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10888000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10233000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	34414000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	410000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	984000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	34004000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	35314000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49569000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49199000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49835000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49402000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	34414000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	410000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	984000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	34004000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	35314000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-982000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1571000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33022000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36885000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.59
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.57
CY2024Q1	us-gaap	Profit Loss ProfitLoss	34414000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12998000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10698000	usd
CY2024Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2669000	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1258000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2074000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3982000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	422000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	28000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	984000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-308000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4164000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3369000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1070000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	117000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7510000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6254000	usd
CY2024Q1	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	11804000	usd
CY2023Q1	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	282000	usd
CY2024Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-11046000	usd
CY2023Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	5577000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3284000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5744000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-49221000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-61200000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2423000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	1184000	usd
CY2024Q1	cns	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	826000	usd
CY2023Q1	cns	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-1067000	usd
CY2024Q1	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	16917000	usd
CY2023Q1	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	1184000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5504000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3515000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-11171000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3507000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4863000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14966000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	93560000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	38536000	usd
CY2024Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	68525000	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	8115000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4326000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4586000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29361000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35007000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	357000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	387000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19364000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20441000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	29301000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28101000	usd
CY2024Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-15938000	usd
CY2023Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	2239000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	15000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	603000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-64261000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-46519000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-88759000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-96492000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-708000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1409000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	189603000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	248714000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100136000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153631000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99521000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149518000	usd
CY2024Q1	cns	Cash Held In Consolidated Investment Vehicles Operating Activities CashHeldInConsolidatedInvestmentVehiclesOperatingActivities	615000	usd
CY2023Q1	cns	Cash Held In Consolidated Investment Vehicles Operating Activities CashHeldInConsolidatedInvestmentVehiclesOperatingActivities	4113000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100136000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153631000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1200000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3300000	usd
CY2024Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	900000	usd
CY2023Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	800000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes the estimates used in preparing the condensed consolidated financial statements are reasonable and prudent. Actual results could differ from those estimates.</span></div>
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	122710000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126082000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	122710000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126082000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	195101000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	180958000	usd
CY2024Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	77926000	usd
CY2023Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	77996000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	13000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	16000	usd
CY2024Q1	us-gaap	Investments Investments	273040000	usd
CY2023Q4	us-gaap	Investments Investments	258970000	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2226000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2330000	usd
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3210000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2022000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	984000	usd
CY2024Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	71366	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	772000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-221000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	34414000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	410000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	984000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	34004000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	35314000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49569000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49199000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	266000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	203000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49835000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49402000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	66000	shares
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.031
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.009
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.030
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.006
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.046
CY2024Q1	cns	Effective Income Tax Rate Reconciliation Valuation Allowance On Corporate Seed Investments Adjustments Percent EffectiveIncomeTaxRateReconciliationValuationAllowanceOnCorporateSeedInvestmentsAdjustmentsPercent	-0.002
CY2023Q1	cns	Effective Income Tax Rate Reconciliation Valuation Allowance On Corporate Seed Investments Adjustments Percent EffectiveIncomeTaxRateReconciliationValuationAllowanceOnCorporateSeedInvestmentsAdjustmentsPercent	0
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.225
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001284812-24-000195-index-headers.html	Edgar Link	pending
0001284812-24-000195-index.html	Edgar Link	pending
0001284812-24-000195.txt	Edgar Link	pending
0001284812-24-000195-xbrl.zip	Edgar Link	pending
cns-20240331.htm	Edgar Link	pending
cns-20240331.xsd	Edgar Link	pending
cns-20240331_g1.jpg	Edgar Link	pending
cns10q-33124ex311.htm	Edgar Link	pending
cns10q-33124ex312.htm	Edgar Link	pending
cns10q-33124ex321.htm	Edgar Link	pending
cns10q-33124ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
cns-20240331_def.xml	Edgar Link	unprocessable
cns-20240331_lab.xml	Edgar Link	unprocessable
cns-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cns-20240331_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cns-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNS
COHEN & STEERS, INC. Stock $cns

2024 Q2 Form 10-Q Financial Statement

#000128481224000195 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNS COHEN & STEERS, INC. Stock $cns

2024 Q2 Form 10-Q Financial Statement

#000128481224000195 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNS
COHEN & STEERS, INC. Stock $cns